Marvin Edeas - A World-recognised Scientist
Marvin Edeas (Découvrir le profil Linkedin.com) is co-editor of the Mitochondria Society's company magazine and moreover chairs its yearly congress, as a former Chair and a founder. His annual congress, Paris Redox, is quite logically taken control of by the Chair of the International Society of Antioxidants. Marvin Edeas chairs a variety of committees of a scientific nature, including that of the Congress on Targeting Microbiota, Mitochondria and Glycation & Maillard Reaction.
There were two works of reference on mitochondrial medicine published by Marvin Edeas back in 2015. Multiple publications, primarily centred on mitochondria, microbiota and chronic diseases are among the topics addressed by him. He looked at the outcomes of oxidative stress in HIV replication in symptomatic and asymptomatic HIV-infected patients in his thesis which was defended in the year 1996. As well as his own publications, the research Marvin Edeas conducts is frequently the subject of reports in the specialised press.
Research on microbiota and mitochondria, cell signalling, the activation of Nrf2 transcription factors and their implications in different pathologies are the primary focus of Marvin Edeas’ research. In particular, he investigates the connection between mitochondria and microbiota. He is the founder and Chair of the International Society of Antioxidants in Nutrition & Health (ISANH) which was established in the year 1998. He, ISANH and the SFA aim to transfer their research to real applications whether clinical, pharmaceutical, nutritional or cosmetic. The French Society of Antioxidants is chaired by Marvin Edeas.
The patents of Marvin Edeas tied into the usage of an oyster enzyme hydrolyzate in a composition that modulates oxidative stress and eliminates free radicals. Cosmetology, dietetics and medicine all stand to reap benefits from Oyster hydrolyzate. A start-up was created in order to market the new peptide thanks to these patents.
Marvin Edeas - Important Research on HIV
Back when the first clinical study on the effects of antiretroviral therapy on lactic acidosis and hyperlactatemia occurred, Marvin Edeas was a participant. He was rewarded by Sidaction for his work with HIV. The factors which produce blastogenic plasma in Type 1 cases of HIV were identified by him in 1997. Marvin Edeas pointed out the role of oxidative stress and co-infections in patients suffering with HIV at the Paris Descartes University.